AI Article Synopsis
Article Abstract
Objectives: An analysis of the results achieved with intracordal autologous fat injection for unilateral laryngeal nerve paralysis after surgery.
Patients And Method: A study group of 46 patients with unilateral laryngeal nerve paralysis was treated by intracordal injection of autologous fat with a minimum follow-up of eight months. All patients had severe dysphonia and 39 had breathlessness. Twenty-nine patients had aspiration problems with difficulties in swallowing.
Results: The only adverse side-effect was a subcutaneous abdominal hematoma in two patients and the development of an intracordal cyst in two patients. Aspiration disappeared immediately after the intracordal injection. Immediate improvement of speech, cough, and breathlessness was achieved in all patients. Over time, speech and voice, and swallowing remained stable in 67% and 80% of patients, respectively.
Conclusion: Such data suggest that the intracordal injection of autologous fat is a valuable method in patients with unilateral laryngeal nerve paralysis after surgery.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/s0001-4001(99)80094-4 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Prevention and Management of Recurrent Laryngeal Nerve Palsy in Minimally Invasive Esophagectomy: Current Status and Future Perspectives.
J Clin Med
December 2024
Department of Surgery, Tohoku University Graduate School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai 980-8575, Miyagi, Japan.
Recurrent laryngeal nerve palsy remains a significant complication following minimally invasive esophagectomy for esophageal cancer. Despite advancements in surgical techniques and lymphadenectomy precision, the incidence of recurrent laryngeal nerve palsy has not been improved. Recurrent laryngeal nerve palsy predominantly affects the left side and may lead to unilateral or bilateral vocal cord paralysis, resulting in hoarseness, dysphagia, and an increased risk of aspiration pneumonia.
View Article and Find Full Text PDFTiming of Intracordal Trafermin Injection in Patients With Vocal Fold Paralysis: Recommendations for a New Treatment Time Course.
J Voice
December 2024
Tokyo Voice Center, International University of Health and Welfare, Tokyo, Japan; School of Medicine, International University of Health and Welfare, Narita, Japan.
Objective: To identify factors correlated with the effect of intracordal trafermin injection.
Study Design: Retrospective cohort study.
Methods: Herein, 177 patients who received an intracordal trafermin injection at the Tokyo Voice Center for vocal fold paralysis were included.
Acute Effects of Steroids on Vocal Fold Epithelium Post-injury in a Preclinical Model.
Laryngoscope
January 2025
Department of Otolaryngology-Head and Neck Surgery, NYU Grossman School of Medicine, New York, New York, U.S.A.
Article Synopsis
- Glucocorticoids (GCs) are widely used for treating laryngeal conditions due to their strong anti-inflammatory effects, yet their impact on vocal fold (VF) tissue recovery after injury is not well understood.
- A study induced microflap injuries in rabbits and later administered GCs (dexamethasone, methylprednisolone, and triamcinolone) to assess changes in epithelial structure and barrier function.
- Results showed that GCs helped maintain barrier function and increased epithelial depth over time, but effects varied between the different types of GCs used, indicating possible differences in their therapeutic effectiveness.
Platelet Rich plasma injection of the vocal folds in benign vocal pathologies.
Eur Arch Otorhinolaryngol
October 2024
Department of Surgery, University of Auckland, Private Bag 91019, Grafton Auckland, New Zealand.
Article Synopsis
- The study investigates the use of platelet rich plasma (PRP) injections as a treatment for dysphonia caused by various vocal fold pathologies, focusing on feasibility, phonatory effects, patient satisfaction, and durability.
- A total of 75 PRP injections were given to 48 patients, showing significant improvements in voice-related quality of life scores (VHI-10) and high patient satisfaction, with 95.7% expressing willingness for future injections.
- The findings suggest that PRP injections are a safe and effective treatment option for benign vocal fold disorders, with even a single injection providing long-lasting benefits for some patients.
Effects of intracordal trafermin injection on mutational voice disorder.
Am J Otolaryngol
March 2024
Tokyo Voice Center, International University of Health and Welfare, Tokyo, Japan. Electronic address:
Introduction: Mutational voice disorder is the inability of the voice to adjust to the changes in the larynx during puberty, resulting in the speaking fundamental frequency failing to decrease. Standard treatments for mutational voice disorder are voice therapy and thyroplasty. However, voice therapy takes time to show its effects, and thyroplasty is highly invasive.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!